Kerr  Holbrook net worth and biography

Kerr Holbrook Biography and Net Worth

As Senior Vice President and Chief Commercial Officer, Kerr Holbrook leads the company’s Specialty Nutrition Systems and Pain Management & Recovery franchises with responsibility for innovation, strategy, execution, and the global P&L success of each business.

Kerr has more than 30 years of experience in the medical device and pharma/biotech industries, including extensive experience driving global growth via new product development, M&A, and commercial execution.

He started his career in sales and sales management with Eli Lilly & Company and led marketing and business development functions for McKesson Corporation. Prior to joining Avanos, Kerr held positions in marketing, business development, and general management with Covidien’s Minimally Invasive Therapies Group (now part of Medtronic), and as Chief Commercial Officer with AlloSource, a regenerative medicine company focused on sports, spine, and orthopedic applications.

He joined Avanos in 2019 as the Senior Vice President and General Manager of the company’s Chronic Care franchise.

Kerr has a bachelor’s degree in business from The University of Kansas and a master’s of business administration degree from the Kellogg Graduate School of Management at Northwestern University.

What is Kerr Holbrook's net worth?

The estimated net worth of Kerr Holbrook is at least $933.78 thousand as of November 18th, 2025. Holbrook owns 83,860 shares of Avanos Medical stock worth more than $933,781 as of December 4th. This net worth evaluation does not reflect any other investments that Holbrook may own. Additionally, Holbrook receives an annual salary of $747,610.00 as SVP at Avanos Medical. Learn More about Kerr Holbrook's net worth.

How old is Kerr Holbrook?

Holbrook is currently 57 years old. There are 3 older executives and no younger executives at Avanos Medical. The oldest executive at Avanos Medical is Mr. Joseph F. Woody, CEO & Director, who is 58 years old. Learn More on Kerr Holbrook's age.

What is Kerr Holbrook's salary?

As the SVP of Avanos Medical, Inc., Holbrook earns $747,610.00 per year. There are 3 executives that earn more than Holbrook. The highest earning executive at Avanos Medical is Mr. Joseph F. Woody, CEO & Director, who commands a salary of $2,210,000.00 per year. Learn More on Kerr Holbrook's salary.

How do I contact Kerr Holbrook?

The corporate mailing address for Holbrook and other Avanos Medical executives is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. Avanos Medical can also be reached via phone at (844) 428-2667 and via email at [email protected]. Learn More on Kerr Holbrook's contact information.

Has Kerr Holbrook been buying or selling shares of Avanos Medical?

Within the last three months, Kerr Holbrook has sold $165,000.00 of Avanos Medical stock. Most recently, Kerr Holbrook sold 15,000 shares of the business's stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $11.00, for a transaction totalling $165,000.00. Following the completion of the sale, the senior vice president now directly owns 83,860 shares of the company's stock, valued at $922,460. Learn More on Kerr Holbrook's trading history.

Who are Avanos Medical's active insiders?

Avanos Medical's insider roster includes Kerr Holbrook (SVP), Patrick O'Leary (Director), and Julie Shimer (Director). Learn More on Avanos Medical's active insiders.

Are insiders buying or selling shares of Avanos Medical?

During the last twelve months, Avanos Medical insiders bought shares 2 times. They purchased a total of 60,000 shares worth more than $659,000.00. During the last twelve months, insiders at the sold shares 2 times. They sold a total of 22,000 shares worth more than $271,750.00. The most recent insider tranaction occured on November, 18th when SVP Kerr Holbrook sold 15,000 shares worth more than $165,000.00. Insiders at Avanos Medical own 2.6% of the company. Learn More about insider trades at Avanos Medical.

Information on this page was last updated on 11/18/2025.

Kerr Holbrook Insider Trading History at Avanos Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2025Sell15,000$11.00$165,000.0083,860View SEC Filing Icon  
3/6/2025Sell7,000$15.25$106,750.0082,047View SEC Filing Icon  
See Full Table

Kerr Holbrook Buying and Selling Activity at Avanos Medical

This chart shows Kerr Holbrook's buying and selling at Avanos Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avanos Medical Company Overview

Avanos Medical logo
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Read More

Today's Range

Now: $11.14
Low: $11.06
High: $11.39

50 Day Range

MA: $11.44
Low: $10.65
High: $11.99

2 Week Range

Now: $11.14
Low: $9.30
High: $19.18

Volume

370,391 shs

Average Volume

523,218 shs

Market Capitalization

$516.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09